Finance

Earnings season may kick-off with an upside surprise. National Securities’ Art Hogan is optimistic the banks’ second quarter results will come in better than expected and help lift stocks. “I don’t think expectations for bank earnings have ever been as low as they are coming into this quarter,” the firm’s chief market strategist told CNBC’s
0 Comments
The headquarters of German immunotherapy company BioNTech stands on April 22, 2020 in Mainz, Germany. Thomas Lohnes | Getty Images Check out the companies making headlines midday Monday: Pfizer, BioNTech — Shares of Pfizer and BioNTech jumped 4.4% and 12.6%, respectively, after two experimental coronavirus vaccines jointly developed by the U.S. pharmaceutical giant and German
0 Comments
Wilmington Trust’s Meghan Shue sees a battle is underway on Wall Street as coronavirus cases surge and companies get ready to report second quarter earnings. According to the firm’s head of investment strategy, there’s a tug-of-war between market skepticism and fear of missing out. “We are definitely seeing a tremendous amount of skepticism about this
0 Comments